CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 161 filers reported holding CASTLE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,033,837 | +34.2% | 1,482,170 | +9.0% | 0.02% | +38.5% |
| Q2 2023 | $18,659,214 | -36.2% | 1,360,001 | +5.7% | 0.01% | -38.1% |
| Q1 2023 | $29,243,980 | +36.4% | 1,287,147 | +41.3% | 0.02% | +31.2% |
| Q4 2022 | $21,440,703 | +88.7% | 910,820 | +109.0% | 0.02% | +77.8% |
| Q3 2022 | $11,364,000 | +107.4% | 435,740 | +74.5% | 0.01% | +125.0% |
| Q2 2022 | $5,480,000 | -31.2% | 249,676 | +40.7% | 0.00% | -20.0% |
| Q1 2022 | $7,961,000 | +1.7% | 177,450 | -2.9% | 0.01% | 0.0% |
| Q4 2021 | $7,831,000 | -30.7% | 182,667 | +7.6% | 0.01% | -28.6% |
| Q3 2021 | $11,293,000 | -8.8% | 169,816 | +0.6% | 0.01% | -12.5% |
| Q2 2021 | $12,380,000 | +104.2% | 168,827 | +90.6% | 0.01% | +100.0% |
| Q1 2021 | $6,063,000 | +15.2% | 88,564 | +13.0% | 0.00% | 0.0% |
| Q4 2020 | $5,262,000 | +261.4% | 78,352 | +176.9% | 0.00% | +300.0% |
| Q3 2020 | $1,456,000 | +45.7% | 28,300 | +6.8% | 0.00% | 0.0% |
| Q2 2020 | $999,000 | – | 26,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |